TWO SIGMA INVESTMENTS, LP - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$41,311
-39.3%
331,287
-49.9%
0.00%
Q4 2022$68,081
-47.2%
660,977
-21.9%
0.00%
Q3 2022$129,000
+174.5%
846,098
+1486.0%
0.00%
Q2 2022$47,000
-90.2%
53,349
-86.2%
0.00%
-100.0%
Q1 2022$479,000
-47.9%
386,602
-18.0%
0.00%
-50.0%
Q4 2021$920,000
-70.0%
471,709
-57.8%
0.00%
-71.4%
Q3 2021$3,065,000
-18.2%
1,118,684
-5.9%
0.01%
-12.5%
Q2 2021$3,746,000
+87.5%
1,189,121
+26.8%
0.01%
+60.0%
Q1 2021$1,998,000
+626.5%
937,956
+562.9%
0.01%
+400.0%
Q4 2020$275,000
+2015.4%
141,498
+640.9%
0.00%
Q3 2020$13,00019,0980.00%
Other shareholders

There were no reported owners of VISTAGEN THERAPEUTICS INC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of VISTAGEN THERAPEUTICS INC shareholders